NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SATT Sud-Est

SATT Sud-Est

Marseillesattse.com

Overview

SATT Sud-Est is a technology transfer accelerator that develops and funds innovations from public research in the Provence-Alpes-Côte d'Azur and Corsica regions of France, with the goal of commercializing them through licensing or startup creation.

Year Founded

2012

Portfolio Companies

7

Website

sattse.com

Investments

SATT Sud-Est investments
CompanyDateStageLead
DimiCare BiotechNov 2025GrantCo-investor
Optipus PVMay 2025SeedCo-investor
Massalia TherapeuticsMay 2025SeedCo-investor
Neocor TherapeuticsJan 2024GrantCo-investor
Roca TherapeuticsSep 2022SeedLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMarseille
Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.